Press release
HLA Typing Market Size in 2023 To 2029 | Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMérieux S.A. (France). Other players in the market are Immucor, Inc.
The HLA typing market is poised for significant growth, projected to reach USD 2.1 billion by 2028 from USD 1.4 billion in 2022, with a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. This growth is driven by the increasing need and strong demand for clinical diagnostic procedures that enable early detection of infectious diseases, graft rejections, autoimmune diseases, and cancer.Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3031601
The prominent player in HLA typing market are Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMérieux S.A. (France). Other players in the market are Immucor, Inc. (US), Illumina, Inc. (US), Luminex Corporation (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), GenDx (Netherlands), and Biofortuna (UK), among others
Research activities in the field of human leukocyte antigen (HLA) typing have been instrumental in advancing diagnostic capabilities. The application of Next-Generation Sequencing (NGS) technologies has greatly contributed to the understanding of the HLA molecule's role in immunity. High-throughput HLA-typing methods utilizing NGS have been developed, allowing for comprehensive HLA sequencing and facilitating the exploration of HLA gene modulation, including transcription, gene expression regulation, and epigenetics.
Government organizations and private entities are actively supporting research initiatives that focus on gene profiling and cross-matching in prospective subjects. This support encourages the adoption of advanced HLA typing techniques and drives market growth.
In 2022, the molecular assay technologies segment held the largest market share in the HLA typing market. This segment's dominance can be attributed to the benefits offered by molecular assay technologies, such as real-time sample analysis, the ability to study multiple samples simultaneously, high procedural efficacy, and quick turnaround times. These advantages make molecular assay technologies highly desirable in HLA typing procedures.
Similarly, in 2022, the reagents and consumables segment accounted for the largest share among all product and service segments in the HLA typing market. The increasing utilization of reagents and consumables in HLA typing procedures, the growing acceptance of these products in research studies, and the emphasis on early and effective treatment planning and transplantation diagnosis across various regions are driving the market growth for this segment. Reagents and consumables are vital components in HLA typing tests, and their demand is expected to continue to grow in the forecast period.
Feel free to ask your queries at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=3031601
North America reported the largest share of 45.0% of the HLA typing market in 2022. This highest share of North America is credited to the increased adoption of developed diagnostics tools, rising incidence and prevalence of chronic disorders in Canada and the US and growing technological developments.
While APAC is expected to witness significant growth in the coming years. The HLA typing market in the APAC region is expected to register a CAGR of 7.5% during the forecast period, primarily due to the growing number of hospitals in Asian countries and favorable government initiatives.
About Us: ReportsnReports - Your Market Research Report Librarian
+ 1 347 333 3771
sales@reportsandreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HLA Typing Market Size in 2023 To 2029 | Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMérieux S.A. (France). Other players in the market are Immucor, Inc. here
News-ID: 3135752 • Views: …
More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…

5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…

Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…

Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for HLA
HLA Typing Market by Size, Share, Forecasts, & Trends Analysis
[Redding, California - Feb 19, 2024] - Meticulous Research®, a renowned global market research entity, is pleased to announce the release of its latest research report, "HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease, Transfusion], Research), End User, and Geography - Global Forecast to 2029."
Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5311
According to Meticulous Research®, the HLA typing market…
HLA Typing Market Is Gaining Huge Growth In Upcoming Years
HLA typing is a type of diagnostic test which is used to identify variations in an individual's immune system. HLA stands for human leukocyte antigen, and it is a critical process to identify the compatibility of a person to donate bone marrow, cord blood, or an organ to a person who is a need of transplantation.
Get Brief Sample Pages of HLA Typing Market Study - https://www.theinsightpartners.com/brochure/TIPRE00009667/?utm_source=OpenPR&utm_medium=10129
HLA typing market is expected…
HLA Typing for Transplant Market worth $1.1 billion by 2028
HLA Typing for Transplant Market in terms of revenue was estimated to be worth $0.8 billion in 2023 and is poised to reach $1.1 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as the increasing transplants volume worldwide, rising number of transplant & diagnostic centers, technological advancements, government initiatives to boost HLA typing services, rising public…
HLA Typing for Transplant Market worth $1.1 billion by 2028
HLA Typing for Transplant Market in terms of revenue was estimated to be worth $0.8 billion in 2023 and is poised to reach $1.1 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as the increasing transplants volume worldwide, rising number of transplant & diagnostic centers, technological advancements, government initiatives to boost HLA typing services, rising public…
HLA Typing Market Sales, Consumption and Forecasts Report 2030
The key objective of the report is to offer a complete assessment of the HLA Typing Market including major leading stakeholders of the HLA Typing industry. The current and historical status of the market together with forecasted market size and trends are demonstrated in the assessment in a simple manner. In addition, the report delivers data on the volume, share, revenue, production, and sales in the market.
The market report on…
HLA Typing for Transplant Market by Top Competitors (HLA typing for transplant m …
Global HLA Typing for Transplant Market report offers a detailed Outlook and future prospects of the Corporate Secretarial Services Industry with analysis of major players that helps Industry experts, analysts and business decision makers to decide their business strategies and achieve proposed business aims.
Get Sample PDF of Report at http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hla-typing-transplant-market
Report Analysis:
Global HLA Typing Market for transplant market is accounted for USD 538.0 million in 2016 growing at a CAGR…